Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVERS.L Regulatory News (VERS)

  • There is currently no data for VERS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Additional Listing & Total Voting Rights

27 Oct 2016 08:41

RNS Number : 6150N
Verseon Corporation
27 October 2016
 

27 October 2016

 

Verseon Corporation

 

("Verseon" or the "Company")

 

Additional Listing & Total Voting Rights

 

Verseon, a technology-based pharmaceutical company, announces that on 25 October 2016, Mr. Grover Wickersham, Non-Executive Director of the Company, has been issued a grant of restricted stock units ("RSUs") that relate to payment of his Director's fees in the form of restricted stock. Mr. Wickersham's restricted stock grant totals 15,463 Common Shares and is calculated by reference to the closing price on 25 October 2016 of the Company's common shares in USD, being $1.94. The RSUs vest quarterly in equal proportions over a 6 month period starting from 30 October 2016.

 

For further information please contact:

 

Verseon Corporation

+1 (510) 225 9000

Arthur Shmurun / Amy Thai

Cenkos Securities (NOMAD and Broker)

+44 (0) 20 7397 8900

Mark Connelly / Steve Cox

Buchanan Communications Ltd (PR Advisers)

+44 (0) 20 7466 5000

Henry Harrison-Topham / Sophie Cowles

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Mr Grover Wickersham

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-Executive Director

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Verseon Corporation

b)

 

LEI

 

 

N/a

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Restricted stock grant of Common Shares of par value $0.001

 

ISIN: USU9221J1098

 

 

b)

 

Nature of the transaction

 

 

Issuance of restricted stock units

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

$1.94

15,463

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

15,463

 

 

$1.94

e)

 

Date of the transaction

 

 

25 October 2016

f)

 

Place of the transaction

 

 

N/a

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAXEXADNKFEF
Date   Source Headline
18th Dec 20194:40 pmRNSSecond Price Monitoring Extn
18th Dec 20194:35 pmRNSPrice Monitoring Extension
11th Dec 20198:18 amRNSTender Offer Results & Special Meeting Notice
9th Dec 20197:00 amRNSResult of Special Shareholder Meeting
29th Nov 20199:05 amRNSSecond Price Monitoring Extn
29th Nov 20199:00 amRNSPrice Monitoring Extension
26th Nov 20192:05 pmRNSSecond Price Monitoring Extn
26th Nov 20192:00 pmRNSPrice Monitoring Extension
26th Nov 20197:00 amRNSCancellation of Depositary Interests Facility
25th Nov 20193:02 pmRNSHolding(s) in Company
25th Nov 20197:00 amRNSHolding(s) in Company
22nd Nov 201911:23 amRNSUpdate on Tender Offer
21st Nov 20194:40 pmRNSSecond Price Monitoring Extn
21st Nov 20194:35 pmRNSPrice Monitoring Extension
20th Nov 20194:33 pmRNSTransaction in Own Shares
20th Nov 20198:33 amRNSIssue of Debt
20th Nov 20197:30 amRNSProposed Cancellation of Admission to AIM
29th Oct 20197:00 amRNSResult of 2019 AGM
24th Oct 20199:43 amRNSUpdate on Facility Sale-Leaseback
23rd Oct 201911:28 amRNSSale-Leaseback of Verseon's Facility
18th Oct 20193:38 pmRNSAnnouncement of 2019 Annual General Meeting
17th Oct 20196:24 pmRNSHolding(s) in Company
16th Oct 20195:24 pmRNSHolding(s) in Company
30th Sep 20197:00 amRNSInterim Results
1st Aug 20194:40 pmRNSSecond Price Monitoring Extn
1st Aug 20194:35 pmRNSPrice Monitoring Extension
1st Aug 20192:05 pmRNSSecond Price Monitoring Extn
1st Aug 20192:00 pmRNSPrice Monitoring Extension
11th Jul 20193:43 pmRNSHolding(s) in Company
3rd Jul 20197:00 amRNSAdditional Listing & Total Voting Rights
28th Jun 20197:00 amRNSFinal Results
25th Jun 20197:00 amRNSAdditional Listing & Total Voting Rights
4th Jun 20197:00 amRNSVerseon showcases oral DME candidates at BIO 2019
30th Apr 20197:00 amRNSVerseon presents DME candidate at ARVO 2019
4th Apr 20197:00 amRNSAdditional Listing & Total Voting Rights
1st Apr 20194:10 pmRNSNew TIDM and ISIN for Subscription Shares
28th Mar 20197:00 amRNSFurther Update to Admission of Subscription Shares
22nd Mar 20197:00 amRNSUpdate to Admission of Subscription Shares
19th Mar 20197:00 amRNSResult of Subscription & Related Party Transaction
18th Mar 20197:00 amRNSVerseon announces security token offering
15th Mar 201912:00 pmRNSChange of TIDM
4th Mar 20197:00 amRNSAdditional Listing & Total Voting Rights
11th Feb 20197:00 amRNSVerseon presents low bleed PROACs at ISC 2019
4th Feb 20197:00 amRNSFirst participant dosed in Verseon clinical trial
29th Jan 20197:00 amRNSDirectorate Change
8th Jan 201912:00 pmRNSAdditional listing confirmation
3rd Jan 201910:20 amRNSAdditional Listing & Total Voting Rights
27th Dec 20187:00 amRNSAdditional Listing and Total Voting Rights
6th Nov 20187:00 amRNSResult of AGM and changes to the Board
5th Nov 20187:00 amRNSAdditional Listing & Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.